Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Leukemia (1)
Oncogene (1)
Nature Reviews Cancer (1)
Nature (1)
Nature Protocols (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (2)
Correspondence (1)
Protocols (1)
Reviews (1)

Subject Check one or more subjects to show results from those subjects only.

Biochemistry
Biological techniques
Cancer
Cell biology
Chemical biology
Drug discovery
Medical research
Physics
Risk factors

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–5 of 5 results

Advanced filters: Author: Norbert Berndt Clear advanced filters

Protein phosphatase 1α-mediated stimulation of apoptosis is associated with dephosphorylation of the retinoblastoma protein

Rui-Hong Wang
Cathy W Y Liu
Norbert Berndt
Research12 Oct 2001
Oncogene

Volume: 20, P: 6111-6122
Smooth trends in fermium charge radii and the impact of shell effects

Laser spectroscopy measurements of the fermium isotopic chain show a smooth trend in the nuclear size of heavy actinide elements, and diminishing shell effects on the size evolution compared with lighter nuclei.

Jessica Warbinek
Elisabeth Rickert
Klaus Wendt
ResearchOpen Access30 Oct 2024
Nature

Volume: 634, P: 1075-1079
Targeting protein prenylation for cancer therapy

It was hoped that targeting protein prenylation would inhibit the oncogenic signalling of RAS family members. However, preclinical and clinical trials of prenyltransferase inhibitors have conflicting results. This Review discusses why these differences might occur and the future of targeting prenylation.

Norbert Berndt
Andrew D. Hamilton
Saïd M. Sebti
Reviews24 Oct 2011
Nature Reviews Cancer

Volume: 11, P: 775-791
Measurement of protein farnesylation and geranylgeranylation in vitro, in cultured cells and in biopsies, and the effects of prenyl transferase inhibitors

Norbert Berndt
Saïd M Sebti
Protocols27 Oct 2011
Nature Protocols

Volume: 6, P: 1775-1791
Identification of novel genetic loci for risk of multiple myeloma by functional annotation

Angelica Macauda
Klara Briem
Federico Canzian
CorrespondenceOpen Access18 Sept 2023
Leukemia

Volume: 37, P: 2326-2329